Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases

Details for Australian Patent Application No. 2007227289 (hide)

Owner Avanir Pharmaceuticals

Inventors Davis, Timothy James; Billich, Andreas; Kumar, Sunil K.C.; Nussbaumer, Peter; Aichholz, Reiner; Sircar, Jagadish; Ying, Wenbin

Agent Davies Collison Cave

Pub. Number AU-A-2007227289

PCT Pub. Number WO2007/109251

Priority 60/801,816 19.05.06 US; 0605689.9 21.03.06 GB; 60/798,059 05.05.06 US

Filing date 20 March 2007

Wipo publication date 27 September 2007

International Classifications

C07D 215/46 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/109251 Priority application(s): WO2007/109251

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227291-Method of increasing the useful life of a sign or display

2007227286-Treatment or prevention of scarring, capsular contractures and/or hyperpigmentation using leukotriene receptor antagonist and vitamin E